YOL013W-B Antibody

What is YOL013W-B and why is it significant for research?

YOL013W-B (also referred to as YOL013W-A in some databases) is a putative protein of unknown function in Saccharomyces cerevisiae. It was identified through SAGE (Serial Analysis of Gene Expression) technology . While its precise function remains undetermined, the protein has garnered research interest due to its potential role in recombination processes, as it has been identified in genome-wide screens for genes affecting spontaneous direct recombination . Understanding this protein's function could provide insights into fundamental cellular processes in yeast, with potential applications in broader eukaryotic biological research.

What is the genomic context of YOL013W-B?

YOL013W-B is a genetic locus in the Saccharomyces cerevisiae genome, with sequence information available in the Saccharomyces Genome Database (SGD). The reference genome sequence derives from laboratory strain S288C . Researchers can access the DNA or protein sequence, view genomic context and coordinates through SGD, which provides comprehensive resources for sequence analysis, including BLAST tools for comparative genomics and design primers for targeted studies .

What known protein interactions does YOL013W-B participate in?

High-throughput affinity capture-mass spectrometry (Affinity Capture-MS) studies have identified an interaction between YOL013W-B and GIS2 (YNL255C) . GIS2 functions as a translational activator for mRNAs with internal ribosome entry sites, associates with polysomes, and binds to specific mRNAs. It localizes to RNA processing bodies and stress granules, potentially playing a role in translation regulation under stress conditions . This interaction suggests YOL013W-B may participate in RNA processing or translational control pathways, though further research is needed to confirm functional significance.

What are the primary research applications for YOL013W-B antibodies?

YOL013W-B antibodies serve multiple critical functions in yeast research, particularly for protein localization studies, interaction analyses, and functional characterization. For subcellular localization experiments, these antibodies can be employed in immunofluorescence microscopy to visualize the native distribution of YOL013W-B within yeast cells under various conditions. In protein interaction studies, YOL013W-B antibodies facilitate co-immunoprecipitation experiments to verify and expand upon the known interaction with GIS2 . Additionally, these antibodies can be used in chromatin immunoprecipitation (ChIP) assays if YOL013W-B is found to associate with DNA, helping to elucidate any potential role in recombination processes suggested by genome-wide screens .

How can researchers validate YOL013W-B antibody specificity for yeast studies?

Validating antibody specificity is essential for reliable research outcomes. For YOL013W-B antibodies, a multi-faceted validation approach is recommended. First, researchers should conduct Western blot analysis comparing wild-type yeast strains with YOL013W-B deletion mutants to confirm the absence of signal in the knockout strain. Second, epitope-tagged versions of YOL013W-B can be created and detected with both anti-tag antibodies and the YOL013W-B antibody to confirm co-localization. Third, peptide competition assays should be performed, where pre-incubation of the antibody with the immunizing peptide should abolish specific signals. Additionally, researchers should consider cross-reactivity testing against related yeast proteins, particularly those with sequence similarity identified through BLASTP analyses available through the Saccharomyces Genome Database .

What experimental controls are essential when using YOL013W-B antibodies?

When designing experiments using YOL013W-B antibodies, several critical controls must be implemented. Negative controls should include YOL013W-B deletion strains processed identically to wild-type samples . Positive controls may incorporate epitope-tagged YOL013W-B expressed in yeast. For immunoprecipitation experiments investigating the YOL013W-B and GIS2 interaction, controls should include reciprocal co-immunoprecipitation using GIS2 antibodies . In microscopy applications, researchers should implement controls for autofluorescence, non-specific secondary antibody binding, and comparison with known subcellular markers. Additionally, when investigating any potential role of YOL013W-B in recombination, appropriate reporter strains with measurable recombination phenotypes should be used as system controls .

What are the main challenges in developing specific antibodies against YOL013W-B?

Developing specific antibodies against YOL013W-B presents several significant challenges. First, as a putative protein of unknown function, YOL013W-B may have low expression levels in standard yeast culture conditions, making native protein isolation difficult. Second, potential sequence similarity with other yeast proteins could result in cross-reactivity issues. Researchers must carefully select unique epitopes through comprehensive sequence analysis using tools available through the Saccharomyces Genome Database . Third, the protein's structure and post-translational modifications remain largely uncharacterized, potentially affecting epitope accessibility in its native state. To address these challenges, researchers should consider developing multiple antibodies targeting different regions of YOL013W-B and thoroughly validate each through knockout strain testing, epitope-tagged protein detection, and peptide competition assays.

How can researchers overcome potential non-specific binding issues with YOL013W-B antibodies?

Non-specific binding represents a significant challenge when working with antibodies against poorly characterized proteins like YOL013W-B. To address this issue, researchers should implement the following optimization strategies: First, conduct detailed titration experiments to determine minimal effective antibody concentrations that maintain specific signals while reducing background. Second, optimize blocking solutions by testing different blocking agents (BSA, non-fat milk, normal serum) and concentrations. Third, implement stringent washing protocols with increased wash steps and/or higher detergent concentrations. Additionally, pre-adsorption of antibodies with yeast lysates from YOL013W-B deletion strains can help remove antibodies that bind to non-target proteins. For particularly problematic non-specific binding, researchers might consider affinity purification of the antibody using recombinant YOL013W-B protein columns to enrich for specific antibodies within the polyclonal population.

What strategies can address the challenge of detecting potentially low-abundance YOL013W-B protein?

YOL013W-B, like many putative proteins of unknown function, may be expressed at low levels or under specific conditions, presenting detection challenges. To overcome this limitation, researchers can implement several strategies: First, explore various growth conditions and stress responses to identify conditions that might upregulate YOL013W-B expression, particularly focusing on conditions that affect known interaction partners like GIS2 . Second, utilize signal amplification techniques such as tyramide signal amplification for immunofluorescence or enhanced chemiluminescence systems for Western blots. Third, consider protein concentration steps through immunoprecipitation prior to detection. Additionally, creating genomically integrated epitope-tagged versions of YOL013W-B under its native promoter can facilitate detection while maintaining physiological expression patterns. If standard conditions yield insufficient protein, controlled overexpression systems can be employed, though researchers must validate that overexpression doesn't create artifacts in localization or interaction studies.

How might YOL013W-B contribute to recombination processes in yeast?

YOL013W-B has been identified in genome-wide screens for genes affecting spontaneous direct recombination, with a reported value of 24.0 in comparison studies . This implicates the protein in recombination pathways, though the precise mechanism remains undetermined. Researchers investigating this function should consider several mechanistic possibilities: YOL013W-B may directly interact with recombination machinery, regulate expression of recombination genes, or influence chromatin structure affecting recombination hotspots. To investigate these hypotheses, researchers should combine YOL013W-B antibody-based ChIP studies with reporter assays measuring recombination rates in wild-type versus deletion strains. Advanced approaches might include synthetic genetic array analysis to map genetic interactions between YOL013W-B and known recombination factors, or proximity-dependent biotin identification (BioID) to identify proximal proteins in the recombination process. Understanding this function could provide insights into genomic stability mechanisms with potential implications beyond yeast biology.

What is the functional significance of the YOL013W-B and GIS2 interaction?

The high-throughput affinity capture-MS studies have identified an interaction between YOL013W-B and GIS2, a translational activator for mRNAs with internal ribosome entry sites that associates with polysomes . This interaction suggests potential roles for YOL013W-B in translation regulation, particularly under stress conditions where GIS2 is known to function. To elucidate the functional significance of this interaction, researchers should implement several advanced approaches: First, conduct ribosome profiling in wild-type and YOL013W-B deletion strains under various stress conditions to identify differentially translated mRNAs. Second, perform RNA immunoprecipitation followed by sequencing (RIP-seq) with both YOL013W-B and GIS2 antibodies to identify shared target mRNAs. Third, employ proximity ligation assays to visualize where in the cell this interaction occurs, particularly in relation to RNA processing bodies and stress granules where GIS2 localizes . Additionally, researchers should investigate whether the YOL013W-B-GIS2 interaction is regulated by specific stress conditions and what domains of each protein mediate the interaction. The table below summarizes potential experimental approaches:

How does YOL013W-B expression vary across different growth conditions and stress responses?

Understanding the expression pattern of YOL013W-B across various conditions could provide critical insights into its function. While YOL013W-B has been identified by SAGE , comprehensive expression profiling remains lacking. Researchers should implement a systematic approach to characterize expression patterns: First, utilize YOL013W-B antibodies in quantitative Western blot analyses across a matrix of growth conditions (different carbon sources, nutrient limitations) and stress conditions (oxidative, heat, osmotic, DNA damage). Second, create reporter constructs with the YOL013W-B promoter driving expression of quantifiable markers like GFP or luciferase to enable high-throughput screening of conditions. Third, perform ribosome profiling to distinguish between transcriptional and translational regulation. Additionally, researchers should examine expression in different cell cycle phases and during yeast developmental processes like sporulation. Correlation of expression patterns with those of interaction partners like GIS2 or with cellular recombination rates could provide functional insights. This comprehensive expression profiling would provide a foundation for understanding when YOL013W-B function is most relevant to cellular physiology.

What are the recommended protocols for immunoprecipitation of YOL013W-B and its interaction partners?

For successful immunoprecipitation of YOL013W-B and verification of its interaction with GIS2 , researchers should implement the following optimized protocol:

Sample Preparation:

• Grow yeast cultures to mid-log phase (OD600 0.6-0.8) in appropriate media

• Harvest cells by centrifugation (3,000 × g, 5 minutes, 4°C)

• Wash cell pellet twice with ice-cold PBS

• Resuspend in lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitor cocktail)

• Lyse cells using glass beads (5 cycles of 1 minute vortexing, 1 minute ice)

• Clear lysate by centrifugation (16,000 × g, 10 minutes, 4°C)

Immunoprecipitation:

• Pre-clear lysate with Protein A/G beads (1 hour, 4°C, rotation)

• Incubate cleared lysate with YOL013W-B antibody (5 μg) overnight at 4°C

• Add Protein A/G beads and incubate for 3 hours at 4°C

• Wash beads 3× with lysis buffer and 2× with wash buffer (lysis buffer without detergents)

• Elute bound proteins with SDS sample buffer (95°C, 5 minutes)

• Analyze by SDS-PAGE and Western blotting for both YOL013W-B and GIS2

For RNA-dependent interactions, include parallel samples with RNase treatment prior to immunoprecipitation. Controls should include immunoprecipitation with non-specific IgG and samples from YOL013W-B deletion strains. For reciprocal verification, perform the same protocol using GIS2 antibodies and detect YOL013W-B in the precipitate.

What experimental design is recommended for investigating YOL013W-B's potential role in recombination?

To systematically investigate YOL013W-B's role in recombination processes , researchers should implement a multi-faceted experimental design:

Recombination Rate Analysis:

• Construct reporter strains in both wild-type and YOL013W-B deletion backgrounds containing a direct repeat recombination cassette (e.g., duplicated LEU2 fragments with an intervening URA3 marker)

• Perform fluctuation tests with multiple independent cultures (minimum 5-10) following Luria-Delbrück methodology

• Plate appropriate dilutions on selective media to quantify recombination events

• Calculate recombination rates using appropriate statistical methods (e.g., Method of the Median or Maximum Likelihood)

Mechanistic Investigation:

• Perform epistasis analysis by creating double mutants with known recombination pathway components

• Use ChIP with YOL013W-B antibodies to assess association with recombination hotspots

• Analyze DNA damage sensitivity phenotypes in YOL013W-B deletion strains

• Monitor Rad52 focus formation (a marker of recombination) in wild-type versus YOL013W-B deletion strains

Expression Analysis:

• Quantify expression of recombination genes in YOL013W-B deletion versus wild-type strains

• Assess YOL013W-B expression in response to recombination-inducing agents

This comprehensive approach will help determine whether YOL013W-B affects recombination directly through protein interactions or indirectly through gene expression regulation or chromatin structure modifications.

What methods should be used to characterize the subcellular localization of YOL013W-B?

Determining the subcellular localization of YOL013W-B is crucial for understanding its function. Researchers should employ multiple complementary approaches:

Immunofluorescence Microscopy:

• Fix yeast cells with 4% paraformaldehyde (15 minutes, room temperature)

• Permeabilize with zymolyase to remove cell wall (30 minutes, 30°C)

• Block with 1% BSA in PBS (1 hour, room temperature)

• Incubate with YOL013W-B primary antibody (overnight, 4°C)

• Wash and incubate with fluorophore-conjugated secondary antibody

• Counterstain with DAPI for nuclear visualization

• Image using confocal microscopy

Subcellular Fractionation:

• Perform sequential cell fractionation to isolate nuclear, cytoplasmic, membrane, and organelle fractions

• Analyze fractions by Western blotting with YOL013W-B antibodies

• Include marker proteins for each fraction as controls (e.g., histone H3 for nucleus, PGK1 for cytoplasm)

Fluorescent Protein Tagging:

• Create C-terminal and N-terminal GFP fusions of YOL013W-B under native promoter control

• Verify functionality of fusion proteins

• Perform live-cell imaging under various conditions

• Co-localize with RFP-tagged cellular markers

For dynamic localization studies, monitor changes in YOL013W-B localization during cell cycle progression and in response to stresses, particularly those affecting its interaction partner GIS2, such as conditions that induce stress granule formation . This comprehensive localization analysis will provide insights into the cellular compartments where YOL013W-B functions.

What are the most promising research directions for understanding YOL013W-B function?

Based on current knowledge, several high-priority research directions emerge for elucidating YOL013W-B function. First, detailed characterization of its role in recombination processes through genetic and biochemical approaches could reveal novel mechanisms of genome maintenance. Second, investigating the functional relationship with GIS2 may uncover roles in stress-responsive translational regulation. Third, comprehensive expression profiling across diverse conditions could identify the physiological contexts where YOL013W-B function is most relevant. Additionally, evolutionary analysis comparing YOL013W-B across fungal species might provide insights into conserved functional domains. The development of specific, validated antibodies against YOL013W-B remains a foundational need for advancing all these research directions. As technologies evolve, approaches like Cryo-EM structural studies and spatial transcriptomics may further illuminate YOL013W-B's cellular functions and provide a more complete understanding of this putative protein's role in yeast biology.